1,000
Participants
Start Date
May 31, 2012
Primary Completion Date
December 31, 2012
Study Completion Date
December 31, 2012
Bivalent OPV 2 week interval
Group A will receive 3 doses of bOPV at 6, 8 and 10 weeks of age (2-week interval between doses).
Bivalent OPV 4 week interval
Group B will receive 3 doses of bOPV at 6, 10 and 14 weeks of age (4-week interval between doses).
Monovalent OPV 2 week interval
Group C will receive 3 doses of mOPV1 at 6, 8 and 10 weeks of age (2-week interval between doses).
Monovalent OPV 4 week interval
Group D will receive 3 doses of mOPV1 at 6, 10 and 14 weeks of age (4-week interval between doses).
Trivalent OPV 4 week interval
Group E will receive 3 doses of tOPV at 6, 10 and 14 weeks of age (4-week interval between doses and similar to the current routine immunization schedule).
Mirpur, Dhaka
Matlab, Matlab
International Centre for Diarrhoeal Disease Research, Bangladesh
OTHER